journal article·2022-05-11Open access

Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker

Asta Kausaite-Minkstimiene, Anton Popov, Almira Ramanaviciene

ACS Applied Materials & Interfaces· Volume 14· Issue 18

Abstract

A surface plasmon resonance (SPR) immunosensor signal amplification strategy based on antibody-functionalized gold-coated magnetic nanoparticles (mAuNPs) was developed for ultrasensitive and quantitative detection of the CD5 biomarker using an indirect sandwich immunoassay format. The gold surface of the SPR sensor disk and mAuNPs was modified with a self-assembled monolayer of 11-mercaptoundecanoic acid (11-MUA), and the coupling method using N-(3-(dimethylamino)propyl)-N'-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide was used to immobilize capture antibodies against human CD5 (anti-CD52A) and detection antibodies against human CD5 (anti-CD52B), respectively. The mAuNPs and anti-CD52B conjugates (mAuNPs-anti-CD52B) were separated by an external magnetic field and used to amplify the SPR signal after the formation of the anti-CD52A/CD5 immune complex on the SPR sensor disk. Compared to the direct CD5 detection with a limit of detection (LOD) of 1.04 nM and a limit of quantification (LOQ) of 3.47 nM, the proposed sandwich immunoassay utilizing mAuNPs-anti-CD52B significantly improved the LOD up to 8.31 fM and the LOQ up to 27.70 fM. In addition, it showed satisfactory performance in human blood serum (recovery of 1.04 pM CD5 was 109.62%). These results suggest that the proposed signal amplification strategy has superior properties and offers the potential to significantly increase the sensitivity of the analysis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Plasmonic and Surface Plasmon Research · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanotechnas − Center of Nanotechnology and Materials Science, Institute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko street 24, LT-03225 Vilnius, Lithuania

Department of Immunology, State Research Institute Centre for Innovative Medicine, Santariskiu street 5, LT-08406 Vilnius, Lithuania

Funding

Lietuvos Mokslo Taryba · European Social Fund

References (41)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1016/S1470-2045(19)30658-810.1016/S1470-2045(19)30658-8 ↗
3. 10.1016/B978-0-12-822859-3.00009-210.1016/B978-0-12-822859-3.00009-2 ↗
4. 10.1039/c3ay40614h10.1039/c3ay40614h ↗
5. 10.1016/j.bios.2016.03.03810.1016/j.bios.2016.03.038 ↗
6. 10.1038/s41598-019-49998-x10.1038/s41598-019-49998-x ↗
7. 10.1038/srep3314010.1038/srep33140 ↗
8. 10.3389/FCHEM.2019.0004010.3389/FCHEM.2019.00040 ↗
9. 10.1016/j.aca.2015.12.02010.1016/j.aca.2015.12.020 ↗
10. 10.1002/anie.20100560710.1002/anie.201005607 ↗
11. 10.1016/j.colsurfa.2019.12358010.1016/j.colsurfa.2019.123580 ↗
12. 10.1016/j.talanta.2018.09.02310.1016/j.talanta.2018.09.023 ↗
13. 10.1016/j.snb.2017.04.16210.1016/j.snb.2017.04.162 ↗
14. 10.1016/j.aca.2012.05.04310.1016/j.aca.2012.05.043 ↗
15. 10.05.2008/jcpsp.31031110.05.2008/jcpsp.310311 ↗
16. 10.3349/ymj.2011.52.5.85110.3349/ymj.2011.52.5.851 ↗
17. 10.18632/oncotarget.347910.18632/oncotarget.3479 ↗
18. 10.1093/annonc/mdn39210.1093/annonc/mdn392 ↗
19. 10.1002/ajh.2429910.1002/ajh.24299 ↗
20. 10.1182/blood-2015-02-62952710.1182/blood-2015-02-629527 ↗
21. 10.1186/S13045-019-0732-7/FIGURES/510.1186/S13045-019-0732-7/FIGURES/5 ↗
22. 10.3390/bios1202006510.3390/bios12020065 ↗
23. 10.1016/j.colsurfb.2017.12.01910.1016/j.colsurfb.2017.12.019 ↗
24. Hamifton R. G. · Clin. Chem. · 1987 · 33 · 170710.1093/clinchem/33.10.1707 ↗
25. 10.1021/jp983325z10.1021/jp983325z ↗
26. 10.1016/j.elecom.2014.05.01110.1016/j.elecom.2014.05.011 ↗
27. 10.1016/j.cplett.2016.12.05310.1016/j.cplett.2016.12.053 ↗
28. 10.1016/j.talanta.2009.01.01210.1016/j.talanta.2009.01.012 ↗
29. 10.1034/j.1399-0039.1999.540203.x10.1034/j.1399-0039.1999.540203.x ↗
30. 10.1093/rheumatology/40.9.105610.1093/rheumatology/40.9.1056 ↗
31. 10.1016/0165-2478(92)90014-F10.1016/0165-2478(92)90014-F ↗
32. 10.1046/j.1365-2222.2001.01124.x10.1046/j.1365-2222.2001.01124.x ↗
33. 10.1016/j.jcrc.2015.04.12010.1016/j.jcrc.2015.04.120 ↗
34. 10.1007/S11033-019-05087-W/FIGURES/410.1007/S11033-019-05087-W/FIGURES/4 ↗
35. 10.21037/tlcr-19-44510.21037/tlcr-19-445 ↗
36. 10.1007/s00216-012-6308-910.1007/s00216-012-6308-9 ↗
37. 10.1016/j.talanta.2015.06.00610.1016/j.talanta.2015.06.006 ↗
38. 10.1016/j.bios.2016.08.07810.1016/j.bios.2016.08.078 ↗
39. 10.1016/j.ab.2006.07.03210.1016/j.ab.2006.07.032 ↗
40. 10.1021/ac900007c10.1021/ac900007c ↗
41. 10.1021/ac200751s10.1021/ac200751s ↗